Cargando…
Cutaneous adverse events and quality of life in outpatients receiving anticancer agents: results from an observational, cross-sectional study
BACKGROUND: Despite growing interest in cutaneous adverse events (CAEs) and their management in patients with cancer, they are often underreported and there are no extensive data on their impact on quality of life (QoL). Healthcare professionals should consider this issue in order to minimize its ne...
Autores principales: | Suh Oh, Hae-Jin, Flórez Menéndez, Ángeles, Sacristán Santos, Víctor, Fernández Ribeiro, Francisca, Vilanova-Trillo, Lucía, Constenla Figueiras, Manuel, Pereiro Ferreiros, Manuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioExcel Publishing Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7413591/ https://www.ncbi.nlm.nih.gov/pubmed/32821263 http://dx.doi.org/10.7573/dic.2020-6-6 |
Ejemplares similares
-
Evaluating health related quality of life in outpatients receiving anti-cancer treatment: results from an observational, cross-sectional study
por: Oh, Hae-Jin Suh, et al.
Publicado: (2021) -
Nivolumab for Metastatic Cutaneous Squamous Cell Carcinoma
por: Oro-Ayude, Marcos, et al.
Publicado: (2020) -
Severe cutaneous adverse reactions induced by targeted anticancer therapies and immunotherapies
por: Chen, Chun-Bing, et al.
Publicado: (2018) -
Cutaneous and Noncutaneous Adverse Effects in Patients with Advanced Melanoma Receiving Immunotherapy
por: Yeung, Howa, et al.
Publicado: (2023) -
892. Risk Factors for Adverse Events in Children Receiving Outpatient Antibiotic Therapy
por: Gillon, Jessica, et al.
Publicado: (2019)